Literature DB >> 793486

Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems.

A Fefer, A B Einstein, M A Cheever.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 793486     DOI： 10.1111/j.1749-6632.1976.tb41723.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor.

Authors:  T J Eberlein; M Rosenstein; P Spiess; R Wesley; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

2.  The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

Authors:  Olle Ringdén; Steven Z Pavletic; Claudio Anasetti; A John Barrett; Tao Wang; Dan Wang; Joseph H Antin; Paolo Di Bartolomeo; Brian J Bolwell; Christopher Bredeson; Mitchell S Cairo; Robert P Gale; Vikas Gupta; Theresa Hahn; Gregory A Hale; Jorg Halter; Madan Jagasia; Mark R Litzow; Franco Locatelli; David I Marks; Philip L McCarthy; Morton J Cowan; Effie W Petersdorf; James A Russell; Gary J Schiller; Harry Schouten; Stephen Spellman; Leo F Verdonck; John R Wingard; Mary M Horowitz; Mukta Arora
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

3.  Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth.

Authors:  S Ben-Efraim; R C Bocian; M B Mokyr; S Dray
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 4.  Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.

Authors:  Conrad R Y Cruz; Catherine M Bollard
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

5.  Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy.

Authors:  Zhi-Chun Ding; Lei Huang; Bruce R Blazar; Hideo Yagita; Andrew L Mellor; David H Munn; Gang Zhou
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

Review 6.  Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects.

Authors:  Zhi-Chun Ding; Gang Zhou
Journal:  Clin Dev Immunol       Date:  2012-02-06

7.  Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.

Authors:  E Fernandez-Cruz; B A Woda; J D Feldman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.